RMD

NYSEStock

ResMed Inc.

$234.76-5.35 (-2.23%)

52-Week Range

$204.54

$293.73

Key Stats

Market Cap

34.3B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.89

Volume

822.9K

Avg Volume

958.6K

Performance

-10.48%

-8.16%

-14.30%

YTD

-5.07%

+5.78%

+11.44%

+24.22%

Price Chart

ETF Exposure

RMD is held by 310 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ITDB	iShares LifePath Target Date 2030 ETF	0.01%	41	$10K	$61.4M	0.09%
PEVC	Pacer PE/VC ETF	0.01%	1	$257	$3.3M	0.85%
AOM	iShares Core 40/60 Moderate Allocation ETF	0.01%	970	$240K	$1.69B	0.20%
IRTR	iShares LifePath Retirement ETF	0.01%	28	$7K	$52.3M	0.08%
AOK	iShares Core 30/70 Conservative Allocation ETF	0.01%	317	$78K	$733.2M	0.20%
XCHG	Alliance Bernstein - AB US Equity ETF	0.01%	132	$34K	$843.7M	0.50%
DFUV	Dimensional - US Marketwide Value ETF	0.00%	2,192	$542K	$13.50B	0.21%
INRO	iShares U.S. Industry Rotation Active ETF	0.00%	4	$988	$32.6M	0.42%
LVHB	Innovator Laddered Allocation Power Buffer ETF	0.00%	1,104	$261K	$782.6M	0.10%
FTLS	First Trust Long/Short Equity ETF	0.00%	0	$0	$2.16B	1.38%

PreviousPage 7 of 7

About RMD ETF Exposure

ResMed Inc. (RMD) is held by 310 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 34.3B, RMD is a widely held institutional stock. The stock currently trades at $234.76. Investors can gain exposure to RMD through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RMD, sorted by portfolio weight.